| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 22.84× | 22.84× | 82.17× | 97.29× | 83.42× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| −9.96× | −4.70× | −25.12× | 56.83× | 2.55× | ||
| 0.75× | 0.75× | 0.73× | 0.81× | 0.80× | ||
| 2.46× | 2.46× | 2.18× | 2.39× | 0.39× | ||
| 1.69× | 1.69× | 1.59× | 1.88× | 0.45× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 83.42 | 97.29 | 82.17 | 22.84 | 22.84 | |
| Working Capital Turnover | 2.55 | 56.83 | -25.12 | -4.70 | -9.96 | |
| Asset Turnover | 0.80 | 0.81 | 0.73 | 0.75 | 0.75 | |
| Cash Conversion (CFO/Net Income) | 0.39 | 2.39 | 2.18 | 2.46 | 2.46 | |
| CFO/EBITDA | 0.45 | 1.88 | 1.59 | 1.69 | 1.69 |